03 February 2021 There is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others the Afriforum regarding access to Ivermectin. SAHPRA wishes to state unequivocally that this is NOT the case. The court deliberations of 2 February...
28 January 2021 The second wave of the COVID-19 epidemic in South Africa has put enormous pressure on all aspects of South Africa’s health system and on its communities. SAHPRA appreciates the frustration and pain experienced by healthcare practitioners, patients and families given the limited availability...
27 January 2021 In an effort to enable and support the country’s response in fighting the COVID-19 pandemic, SAHPRA has on 22 January 2021 granted a Section 21 authorisation to the Department of Health for COVISHIELD (a covid-19 vaccine manufactured by Serum Institute of India) for...
15 December 2020 With the advent of COVID-19, vaccine development is a critical area of need. SAHPRA has been proactive and is prepared for the vaccine registration process. The readiness programme includes the establishment of a specialised working group, the COVID-19 Vaccine Registration Working Group (CVr...
12 November 2020 SAHPRA wishes to correct the inaccuracies in the Medical Brief article titled “High Court rules that SAHPRA not to regulate alternative medicines” published on 4 November 2020. On 01 October 2020, the Pretoria High Court delivered its judgment in the matter between the...
20 October 2020 SAHPRA refutes claims made by the Black Farmers Association of South Africa (BFASA) that SAHPRA is a corrupt entity with an inclination towards White bias, in the issuing of licenses, generally and particularly with respect to cannabis products. SAHPRA is subject to inter...
On 01 October 2020, the Pretoria High Court delivered its judgment in the matter between the Alliance of Natural Health Products in South Africa (“ANHP”) v Minister of Health and SAHPRA. In the application ANHP sought to review and have set aside certain aspects of...
30 March 2020 In line with the recommendation of the South African National Institute for Communicable Disease (NICD) and the recommendation of the World Health Organization (WHO), SAHPRA wishes to point out that the so-called Rapid test kits (serological test kits) that are being offered...
The South African Health Products Regulatory Authority (SAHPRA) has become aware of reports on social media, which raise questions about whether non-steroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen, could worsen coronavirus disease (COVID-19) when used for the symptomatic treatment of pain and fever in patients...
The South African Health Products Regulatory Authority (SAHPRA) worked together with the SANDF, SAPS, Hawks, Metro Police, Department of Home Affairs, Department of Transport and Adams & Adams to seize a shipment containing prohibited skin lightening creams, unregistered medicines and registered schedule 4 medicines worth...
